menu toggle

A Conversation with Jim Cleary

Pharmaceutical Commerce, Nick Basta

Pharmaceutical Commerce sat down with Jim Cleary, AmerisourceBergen Group Vice President of Global Commercialization Services & Animal Health, to find out what’s happening internally at AmerisourceBergen; including how Fusion provides a competitive advantage for Lash Group’s hub services. 

More in the Media

Drug Discovery & Development, Joanne Van Zuidam

Technology that Supports the Patient Journey and Product Lifecycle

November 28, 2017

Pharmaceutical Commerce, Nick Basta

Lash Group Moves Specialty Pharmaceutical Services From 'High Touch' to 'Smart Touch'

October 11, 2017

Pharmaceutical Executive

Lash Group Launches New Technology, Fusion

October 04, 2017

Pharmaceutical Processing

AmerisourceBergen Business Unit Launches New Technology Ecosystem

October 05, 2017